Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
GREAT POINT PARTNERS LLC (CIK 1281446) reported $435.1M across 37 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: APGE ($31.5M, 7.23%), VOR ($31.2M, 7.18%), ZURA ($25.1M, 5.77%), AMLX ($24.3M, 5.59%), IBRX ($23.0M, 5.29%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | APGE | APOGEE THERAPEUTICS INC | $31.5M | 7.23% | 374,000 | Hold |
| 2 | VOR | VOR BIOPHARMA INC | $31.2M | 7.18% | 1.8M | Added |
| 3 | ZURA | ZURA BIO LTD | $25.1M | 5.77% | 4.2M | Added |
| 4 | AMLX | AMYLYX PHARMACEUTICALS INC | $24.3M | 5.59% | 1.8M | Hold |
| 5 | IBRX | IMMUNITYBIO INC | $23.0M | 5.29% | 3.0M | New |
| 6 | NKTR | NEKTAR THERAPEUTICS | $22.8M | 5.23% | 316,453 | Added |
| 7 | SLGL | SOL-GEL TECHNOLOGIES LTD | $21.7M | 5.00% | 274,363 | New |
| 8 | ALMS | ALUMIS INC | $18.9M | 4.33% | 856,061 | New |
| 9 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $16.1M | 3.69% | 220,000 | New |
| 10 | ANNX | ANNEXON INC | $13.8M | 3.18% | 2.5M | New |
| 11 | KALV | KALVISTA PHARMACEUTICALS INC | $13.6M | 3.12% | 675,000 | Trimmed |
| 12 | JBIO | JADE BIOSCIENCES INC | $13.6M | 3.11% | 964,462 | Added |
| 13 | IMVT | IMMUNOVANT INC | $13.6M | 3.11% | 545,625 | Trimmed |
| 14 | CTNM | CONTINEUM THERAPEUTICS INC | $10.5M | 2.40% | 800,198 | Added |
| 15 | ZBIO | ZENAS BIOPHARMA INC | $10.2M | 2.35% | 524,066 | New |
| 16 | NGNE | NEUROGENE INC | $10.1M | 2.32% | 500,000 | Added |
| 17 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $9.3M | 2.14% | 500,000 | New |
| 18 | ELYM | CLIMB BIO INC | $9.1M | 2.10% | 1.3M | Added |
| 19 | ORKA | ORUKA THERAPEUTICS INC | $9.0M | 2.07% | 183,330 | Hold |
| 20 | EPRX | EUPRAXIA PHARMACEUTICALS INC | $8.7M | 2.00% | 1.2M | Hold |
| 21 | VERA | VERA THERAPEUTICS INC | $8.0M | 1.84% | 199,348 | New |
| 22 | EVOMMUNE INC | $7.5M | 1.72% | 325,000 | Hold | |
| 23 | LB PHARMACEUTICALS INC | $7.4M | 1.70% | 300,000 | New | |
| 24 | CMPX | COMPASS THERAPEUTICS INC | $7.1M | 1.64% | 1.4M | New |
| 25 | SCYX | SCYNEXIS INC | $6.9M | 1.59% | 7.6M | New |
Source: SEC Form 13F filings · as of 2026-03-31